Cytosorbents (CTSO) Inventory (2011 - 2026)

Cytosorbents has reported Inventory for 16 years, with the latest figure at $4.5 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 48.45% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (up 48.45% YoY), and the FY2025 full-year result was $5.3 million, up 93.23% from the prior year.
• Inventory for Q1 2026 stood at $4.5 million, down from $5.3 million in the prior quarter.
• The five-year high for Inventory was $5.4 million in Q1 2022, with the low at $1.7 million in Q1 2023.
• Historically, Inventory has averaged $3.7 million across 5 years, with a median of $3.5 million in 2022.
• Annual changes were most pronounced in 2023 — Inventory slumped 68.31% — and 2024, when it soared 116.66%.
• Cytosorbents' Inventory stood at $3.5 million in 2022, then fell by 2.48% to $3.4 million in 2023, then dropped by 19.04% to $2.7 million in 2024, then jumped by 93.23% to $5.3 million in 2025, then fell by 15.15% to $4.5 million in 2026.
• The last three Inventory figures came in at $4.5 million (Q1 2026), $5.3 million (Q4 2025), and $4.0 million (Q3 2025), per Business Quant data.